Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost in the use of enoxaparin compared with unfractionated heparin in patients with atrial fibrillation undergoing a transesophageal echocardiography-guided cardioversion (from Assessment of Cardioversion using Transesophageal Echocardiography [ACUTE] II randomized multicenter study).
Zhao L, Zhang Z, Kolm P, Jasper S, Lewis C, Klein A, Weintraub W; ACUTE II Investigators. Zhao L, et al. Among authors: jasper s. Am J Cardiol. 2008 Feb 1;101(3):338-42. doi: 10.1016/j.amjcard.2007.09.075. Am J Cardiol. 2008. PMID: 18237596 Clinical Trial.
Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.
Klein AL, Murray RD, Becker ER, Culler SD, Weintraub WS, Jasper SE, Lieber EA, Apperson-Hansen C, Heerey AM, Grimm RA; ACUTE Investigators. Klein AL, et al. Among authors: jasper se. J Am Coll Cardiol. 2004 Apr 7;43(7):1217-24. doi: 10.1016/j.jacc.2003.11.030. J Am Coll Cardiol. 2004. PMID: 15063433 Free article. Clinical Trial.
Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.
Hoppensteadt D, Fareed J, Klein AL, Jasper SE, Apperson-Hansen C, Lieber EA, Katz WE, Malouf JF, Stoddard MF, Pape LA; Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Investigators. Hoppensteadt D, et al. Am J Cardiol. 2008 Oct 1;102(7):842-6. doi: 10.1016/j.amjcard.2008.05.025. Epub 2008 Jul 9. Am J Cardiol. 2008. PMID: 18805108 Clinical Trial.
Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies.
Klein AL, Murray RD, Grimm RA, Li J, Apperson-Hansen C, Jasper SE, Goodman-Bizon AS, Lieber EA, Black IW; ACUTE Investigators. Klein AL, et al. Among authors: jasper se. Am J Cardiol. 2003 Jul 15;92(2):161-5. doi: 10.1016/s0002-9149(03)00531-9. Am J Cardiol. 2003. PMID: 12860217 Clinical Trial.
Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.
Klein AL, Grimm RA, Jasper SE, Murray RD, Apperson-Hansen C, Lieber EA, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF; ACUTE Steering and Publications Committee for the ACUTE Investigators. Klein AL, et al. Am Heart J. 2006 Feb;151(2):380-9. doi: 10.1016/j.ahj.2005.07.011. Am Heart J. 2006. PMID: 16442904 Clinical Trial.
87 results